223 related articles for article (PubMed ID: 8985041)
1. Thermosensitive liposomes: extravasation and release of contents in tumor microvascular networks.
Gaber MH; Wu NZ; Hong K; Huang SK; Dewhirst MW; Papahadjopoulos D
Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1177-87. PubMed ID: 8985041
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous measurement of liposome extravasation and content release in tumors.
Wu NZ; Braun RD; Gaber MH; Lin GM; Ong ET; Shan S; Papahadjopoulos D; Dewhirst MW
Microcirculation; 1997 Mar; 4(1):83-101. PubMed ID: 9110286
[TBL] [Abstract][Full Text] [Related]
3. Method of hyperthermia and tumor size influence effectiveness of doxorubicin release from thermosensitive liposomes in experimental tumors.
Willerding L; Limmer S; Hossann M; Zengerle A; Wachholz K; Ten Hagen TL; Koning GA; Sroka R; Lindner LH; Peller M
J Control Release; 2016 Jan; 222():47-55. PubMed ID: 26658073
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release.
Kong G; Anyarambhatla G; Petros WP; Braun RD; Colvin OM; Needham D; Dewhirst MW
Cancer Res; 2000 Dec; 60(24):6950-7. PubMed ID: 11156395
[TBL] [Abstract][Full Text] [Related]
5. Novel temperature-triggered liposome with high stability: formulation, in vitro evaluation, and in vivo study combined with high-intensity focused ultrasound (HIFU).
Park SM; Kim MS; Park SJ; Park ES; Choi KS; Kim YS; Kim HR
J Control Release; 2013 Sep; 170(3):373-9. PubMed ID: 23770213
[TBL] [Abstract][Full Text] [Related]
6. Hyperthermia-triggered intracellular delivery of anticancer agent to HER2(+) cells by HER2-specific affibody (ZHER2-GS-Cys)-conjugated thermosensitive liposomes (HER2(+) affisomes).
Smith B; Lyakhov I; Loomis K; Needle D; Baxa U; Yavlovich A; Capala J; Blumenthal R; Puri A
J Control Release; 2011 Jul; 153(2):187-94. PubMed ID: 21501640
[TBL] [Abstract][Full Text] [Related]
7. Investigation of Particle Accumulation, Chemosensitivity and Thermosensitivity for Effective Solid Tumor Therapy Using Thermosensitive Liposomes and Hyperthermia.
Lokerse WJ; Bolkestein M; Ten Hagen TL; de Jong M; Eggermont AM; Grüll H; Koning GA
Theranostics; 2016; 6(10):1717-31. PubMed ID: 27446503
[TBL] [Abstract][Full Text] [Related]
8. Hyperthermia induces doxorubicin release from long-circulating liposomes and enhances their anti-tumor efficacy.
Ning S; Macleod K; Abra RM; Huang AH; Hahn GM
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):827-34. PubMed ID: 8040030
[TBL] [Abstract][Full Text] [Related]
9. A novel two-step mild hyperthermia for advanced liposomal chemotherapy.
Li L; ten Hagen TL; Haeri A; Soullié T; Scholten C; Seynhaeve AL; Eggermont AM; Koning GA
J Control Release; 2014 Jan; 174():202-8. PubMed ID: 24269966
[TBL] [Abstract][Full Text] [Related]
10. Surrogate MRI markers for hyperthermia-induced release of doxorubicin from thermosensitive liposomes in tumors.
Peller M; Willerding L; Limmer S; Hossann M; Dietrich O; Ingrisch M; Sroka R; Lindner LH
J Control Release; 2016 Sep; 237():138-46. PubMed ID: 27364227
[TBL] [Abstract][Full Text] [Related]
11. The antitumor activity of tumor-homing peptide-modified thermosensitive liposomes containing doxorubicin on MCF-7/ADR: in vitro and in vivo.
Wang C; Wang X; Zhong T; Zhao Y; Zhang WQ; Ren W; Huang D; Zhang S; Guo Y; Yao X; Tang YQ; Zhang X; Zhang Q
Int J Nanomedicine; 2015; 10():2229-48. PubMed ID: 25834435
[TBL] [Abstract][Full Text] [Related]
12. Effects of Surface Charge, PEGylation and Functionalization with Dipalmitoylphosphatidyldiglycerol on Liposome-Cell Interactions and Local Drug Delivery to Solid Tumors via Thermosensitive Liposomes.
Petrini M; Lokerse WJM; Mach A; Hossann M; Merkel OM; Lindner LH
Int J Nanomedicine; 2021; 16():4045-4061. PubMed ID: 34163158
[TBL] [Abstract][Full Text] [Related]
13. Improvement of Antitumor Efficacy by Combination of Thermosensitive Liposome with High-Intensity Focused Ultrasound.
Cha JM; You DG; Choi EJ; Park SJ; Um W; Jeon J; Kim K; Kwon IC; Park JC; Kim HR; Park JH
J Biomed Nanotechnol; 2016 Sep; 12(9):1724-33. PubMed ID: 29345882
[TBL] [Abstract][Full Text] [Related]
14. Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy.
Li L; ten Hagen TL; Hossann M; Süss R; van Rhoon GC; Eggermont AM; Haemmerich D; Koning GA
J Control Release; 2013 Jun; 168(2):142-50. PubMed ID: 23524188
[TBL] [Abstract][Full Text] [Related]
15. Temperature-triggered tumor-specific delivery of anticancer agents by cRGD-conjugated thermosensitive liposomes.
Kim MS; Lee DW; Park K; Park SJ; Choi EJ; Park ES; Kim HR
Colloids Surf B Biointerfaces; 2014 Apr; 116():17-25. PubMed ID: 24441178
[TBL] [Abstract][Full Text] [Related]
16. In depth study on thermosensitive liposomes: Optimizing formulations for tumor specific therapy and in vitro to in vivo relations.
Lokerse WJ; Kneepkens EC; ten Hagen TL; Eggermont AM; Grüll H; Koning GA
Biomaterials; 2016 Mar; 82():138-50. PubMed ID: 26761778
[TBL] [Abstract][Full Text] [Related]
17. Sequential HIFU heating and nanobubble encapsulation provide efficient drug penetration from stealth and temperature sensitive liposomes in colon cancer.
VanOsdol J; Ektate K; Ramasamy S; Maples D; Collins W; Malayer J; Ranjan A
J Control Release; 2017 Feb; 247():55-63. PubMed ID: 28042085
[TBL] [Abstract][Full Text] [Related]
18. Mild hyperthermia accelerates doxorubicin clearance from tumour-extravasated temperature-sensitive liposomes.
Al-Jamal WT; Kostarelos K
Nanotheranostics; 2022; 6(3):230-242. PubMed ID: 35145834
[TBL] [Abstract][Full Text] [Related]
19. In vivo monitoring of tissue pharmacokinetics of liposome/drug using MRI: illustration of targeted delivery.
Viglianti BL; Abraham SA; Michelich CR; Yarmolenko PS; MacFall JR; Bally MB; Dewhirst MW
Magn Reson Med; 2004 Jun; 51(6):1153-62. PubMed ID: 15170835
[TBL] [Abstract][Full Text] [Related]
20. Magnetic Heating Stimulated Cargo Release with Dose Control using Multifunctional MR and Thermosensitive Liposome.
Ray S; Cheng CA; Chen W; Li Z; Zink JI; Lin YY
Nanotheranostics; 2019; 3(2):166-178. PubMed ID: 31183312
[No Abstract] [Full Text] [Related]
[Next] [New Search]